- France
- /
- Electrical
- /
- ENXTPA:MRN
Earnings Update: Here's Why Analysts Just Lifted Their Mersen S.A. (EPA:MRN) Price Target To €28.03
Shareholders of Mersen S.A. (EPA:MRN) will be pleased this week, given that the stock price is up 12% to €24.60 following its latest half-yearly results. Mersen reported in line with analyst predictions, delivering revenues of €610m and statutory earnings per share of €2.37, suggesting the business is executing well and in line with its plan. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.
Taking into account the latest results, Mersen's six analysts currently expect revenues in 2025 to be €1.22b, approximately in line with the last 12 months. Per-share earnings are expected to surge 22% to €2.48. In the lead-up to this report, the analysts had been modelling revenues of €1.22b and earnings per share (EPS) of €2.31 in 2025. The analysts seems to have become more bullish on the business, judging by their new earnings per share estimates.
View our latest analysis for Mersen
The analysts have been lifting their price targets on the back of the earnings upgrade, with the consensus price target rising 8.1% to €28.03. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Mersen, with the most bullish analyst valuing it at €34.20 and the most bearish at €22.00 per share. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.
Of course, another way to look at these forecasts is to place them into context against the industry itself. We would highlight that revenue is expected to reverse, with a forecast 1.7% annualised decline to the end of 2025. That is a notable change from historical growth of 9.1% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 6.3% annually for the foreseeable future. It's pretty clear that Mersen's revenues are expected to perform substantially worse than the wider industry.
The Bottom Line
The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Mersen following these results. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Mersen's revenue is expected to perform worse than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.
With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Mersen analysts - going out to 2027, and you can see them free on our platform here.
And what about risks? Every company has them, and we've spotted 4 warning signs for Mersen you should know about.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ENXTPA:MRN
Mersen
Manufactures and sells electrical power products and advanced materials in France, North America, rest of Europe, the Asia-Pacific, and internationally.
Excellent balance sheet with slight risk.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Adobe: A Probabilistic Case for Undervaluation

A Capital Allocation Favorite with Structural Importance

Good foundation, but now it's all about the next steps
Recently Updated Narratives

An Overlooked AI Play That’s Quietly Building a Healthcare Data Empire
Undervalued, Underestimated
Tanco's Pullback Brings Key Accumulation Zones Into Focus
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Honeywell - The Demand-Side of the AI Infrastructure
Trending Discussion
It's wonderful. It has greatly helped me take informed decisions.

